Tilray Brands, Inc. (NASDAQ:TLRY – Get Free Report) shares were down 1.3% on Wednesday . The company traded as low as $4.28 and last traded at $4.43. Approximately 4,194,126 shares changed hands during trading, a decline of 2% from the average session volume of 4,268,484 shares. The stock had previously closed at $4.49.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on the company. Roth Mkm upgraded Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a report on Thursday, April 2nd. TD Cowen lowered their price objective on Tilray Brands from $10.00 to $7.00 and set a “buy” rating on the stock in a research note on Monday, March 30th. ATB Cormark Capital Markets lowered their price objective on Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 2nd. Weiss Ratings cut Tilray Brands from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 13th. Finally, Wall Street Zen raised Tilray Brands from a “sell” rating to a “hold” rating in a research note on Saturday, March 21st. Three research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Tilray Brands presently has an average rating of “Hold” and a consensus price target of $11.50.
Get Our Latest Analysis on Tilray Brands
Tilray Brands Stock Down 1.3%
Tilray Brands (NASDAQ:TLRY – Get Free Report) last posted its earnings results on Wednesday, April 1st. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.10). Tilray Brands had a negative return on equity of 3.31% and a negative net margin of 156.51%.The business had revenue of $206.73 million for the quarter, compared to analyst estimates of $201.35 million. During the same period last year, the business earned ($0.87) EPS. As a group, equities analysts predict that Tilray Brands, Inc. will post -0.58 earnings per share for the current year.
Insider Activity
In related news, Director David G. Hopkinson sold 33,556 shares of the firm’s stock in a transaction dated Tuesday, April 21st. The stock was sold at an average price of $6.94, for a total transaction of $232,878.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.84% of the company’s stock.
Institutional Investors Weigh In On Tilray Brands
A number of institutional investors have recently made changes to their positions in the stock. Hilton Head Capital Partners LLC purchased a new stake in shares of Tilray Brands in the 4th quarter valued at approximately $38,000. Pictet Asset Management Holding SA boosted its position in shares of Tilray Brands by 38.9% during the 1st quarter. Pictet Asset Management Holding SA now owns 18,387 shares of the company’s stock worth $119,000 after purchasing an additional 5,145 shares during the period. Schonfeld Strategic Advisors LLC increased its holdings in Tilray Brands by 4.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 144,358 shares of the company’s stock valued at $1,304,000 after purchasing an additional 6,182 shares during the last quarter. Baader Bank Aktiengesellschaft increased its holdings in Tilray Brands by 17.7% in the 1st quarter. Baader Bank Aktiengesellschaft now owns 47,938 shares of the company’s stock valued at $293,000 after purchasing an additional 7,226 shares during the last quarter. Finally, IFP Advisors Inc raised its position in Tilray Brands by 14.3% in the fourth quarter. IFP Advisors Inc now owns 60,318 shares of the company’s stock valued at $545,000 after purchasing an additional 7,541 shares during the period. 9.35% of the stock is currently owned by institutional investors and hedge funds.
About Tilray Brands
Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.
Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.
Further Reading
- Five stocks we like better than Tilray Brands
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.
